Aurora Cannabis is down to 73.49 cents, after ending Friday at 73.72 cents. Overall, a 0.31% loss or 0.23 cents today.
Amid the market gloom, United States Participation Rate (Feb) released today at 13:30 UTC with a figure of 118.3, while the previous figure was 62.4.
Trend and momentum analysis indicates that the Commodity Channel Index (CCI) indicator is below -100, meaning the market price is unusually low and below its rolling moving average. Technical analysis indicates that a new, strong downtrend could be forthcoming with short positions favored. According to momentum evaluation, the Relative Strength Index indicates Aurora Cannabis is in an oversold condition, which could precipitate a reversal and set up a new bullish phase. Asset volatility analysis shows that Aurora Cannabis's lower Bollinger Band® is at 72.9831 cents, indicating that the asset has overextended to the downside and could, therefore, bounce back as buyers look for bargains. As the trading day commences, technical analysis suggests Aurora Cannabis reversed direction at 70.8933 cents support zone and climbed 3 cents above it.
All in all, the technical analysis suggests Aurora Cannabis has no clear-cut direction.
Positive performances can be seen by looking at other health care stocks as Eli Lilly and Company added 4.11% to its value, now trading at $327.95. Johnson & Johnson gained 2.35%, currently at $155.18. Amgen is up 3.62% to $236.12.
Furthermore, United States Consumer Price Index is expected tomorrow at 12:30 UTC. United States Consumer Price Index is expected tomorrow at 12:30 UTC. United States Core Consumer Prices is expected tomorrow at 12:30 UTC.
On a negative trend for around a month. Having set a significant high of $4.46 11 months ago, the Canadian cannabis producer is trading 83.47% lower.